Azerbaijan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Azerbaijan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was up 1.1% year on year. At 1,063 Cases in 2019, the country was number 42 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. Azerbaijan is overtaken by Belarus, which was ranked number 41 at 1,182 Cases and is followed by Bangladesh with 1,035 Cases. India lead the ranking with 66,255 Cases in 2019, that is +13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia was the worst growing country at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 1,063.00 |
| 2018 | 1,038.00 |
| 2017 | 1,007.00 |
| 2016 | 925.00 |
| 2015 | 1,171.00 |
How does Azerbaijan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 40 |
#40
Brazil
|
1,190 | 2019 | +3.8 % | +11.6 % | View data | |
| 42 |
#42
Azerbaijan
|
1,063 | 2019 | +2.4 % | +1.1 % | View data | |
| 47 |
#47
Democratic Republic of the Congo
|
960 | 2019 | +6.9 % | +16.8 % | View data | |